Cargando…
Acute Liver Failure following a Single Dose of Atezolizumab, as Assessed for Causality Using the Updated RUCAM
Immune checkpoint inhibitors have become major therapeutic agents in oncology over the last few years. However, they are associated with a variety of potentially severe autoimmune phenomena. We present a patient with advanced adenocarcinoma of the lung, who presented with acute liver injury two week...
Autores principales: | Tzadok, Roie, Levy, Sharon, Aouizerate, Jessie, Shibolet, Oren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967548/ https://www.ncbi.nlm.nih.gov/pubmed/35368450 http://dx.doi.org/10.1155/2022/5090200 |
Ejemplares similares
-
Herb-Induced Liver Injury by Ayurvedic Ashwagandha as Assessed for Causality by the Updated RUCAM: An Emerging Cause
por: Bokan, Goran, et al.
Publicado: (2023) -
RUCAM in Drug and Herb Induced Liver Injury: The Update
por: Danan, Gaby, et al.
Publicado: (2015) -
Causality assessment of skyfruit-induced liver injury using the
updated RUCAM: a case report and review of the literature
por: Xia, Caixia, et al.
Publicado: (2020) -
Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment?
por: Teschke, Rolf, et al.
Publicado: (2017) -
Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score
por: Danjuma, Mohammed Ibn-Mas’ud, et al.
Publicado: (2020)